Literature DB >> 11992009

A nucleotide substitution in the tRNA(Lys) primer binding site dramatically increases replication of recombinant simian immunodeficiency virus containing a human immunodeficiency virus type 1 reverse transcriptase.

Kelly Soderberg1, Lynn Denekamp, Sarah Nikiforow, Karen Sautter, Ronald C Desrosiers, Louis Alexander.   

Abstract

A recombinant simian immunodeficiency virus (SIV) derived from strain 239 (SIVmac239) with reverse transcriptase (RT) sequences from human immunodeficiency virus type 1 (HIV-1) strain HXB2 was severely impaired for replication. Detectable p27(Gag) levels were not observed until day 65 and peak p27(Gag) levels were not reached until day 75 after transfection of CEMx174 cells with the recombinant DNA. Sequences from the latter time point did not contain amino acid substitutions in HIV-1 RT; however, a single nucleotide substitution (thymine to cytosine) was found at position eight of the SIV primer binding site. We engineered an RT/SHIV genome with the thymine-to-cytosine substitution, called RT/SHIV/TC, and observed dramatically faster replication kinetics than were observed with the parental RT/SHIV from which this variant was derived. RT/SHIV/TC provides an improved system for study of the impact of drug resistance mutations in HIV-1 RT in a relevant animal model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11992009      PMCID: PMC137045          DOI: 10.1128/jvi.76.11.5803-5806.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

2.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

Review 3.  An analysis of the role of tRNA species as primers for the transcription into DNA of RNA tumor virus genomes.

Authors:  J M Taylor
Journal:  Biochim Biophys Acta       Date:  1977-03-21

4.  RNA-directed DNA synthesis in Moloney murine leukemia virus: interaction between the primer tRNA and the genome RNA.

Authors:  G Peters; J E Dahlberg
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

5.  Suboptimal nucleotides in the infectious, pathogenic simian immunodeficiency virus clone SIVmac239.

Authors:  L Alexander; L Denekamp; S Czajak; R C Desrosiers
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection.

Authors:  K Mori; Y Yasutomi; S Sawada; F Villinger; K Sugama; B Rosenwith; J L Heeney; K Uberla; S Yamazaki; A A Ansari; H Rübsamen-Waigmann
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

7.  Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection.

Authors:  L Alexander; E Weiskopf; T C Greenough; N C Gaddis; M R Auerbach; M H Malim; S J O'Brien; B D Walker; J L Sullivan; R C Desrosiers
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

8.  Effects of amino acid substitutions at position 115 on the fidelity of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  P L Boyer; S H Hughes
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

9.  tRNA's and priming of RNA-directed DNA synthesis in mouse mammary tumor virus.

Authors:  G Peters; C Glover
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

10.  Binding of tRNA to reverse transcriptase of RNA tumor viruses.

Authors:  A Panet; H Berliner
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

View more
  26 in total

1.  Adaptation of an R5 Simian-Human Immunodeficiency Virus Encoding an HIV Clade A Envelope with or without Ablation of Adaptive Host Immunity: Differential Selection of Viral Mutants.

Authors:  Mingkui Zhou; Michael Humbert; Muhammad M Mukhtar; Hanna B Scinto; Hemant K Vyas; Samir K Lakhashe; Siddappa N Byrareddy; Gregor Maurer; Swati Thorat; Joshua Owuor; Zhao Lai; Yidong Chen; Anthony Griffiths; Agnès-Laurence Chenine; Sanjeev Gumber; François Villinger; David Montefiori; Ruth M Ruprecht
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

2.  The nonnucleoside reverse transcriptase inhibitor MIV-150 in carrageenan gel prevents rectal transmission of simian/human immunodeficiency virus infection in macaques.

Authors:  R Singer; N Derby; A Rodriguez; L Kizima; J Kenney; M Aravantinou; A Chudolij; A Gettie; J Blanchard; J D Lifson; M Piatak; J A Fernández-Romero; T M Zydowsky; M Robbiani
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

3.  In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.

Authors:  Zandrea Ambrose; Valerie Boltz; Sarah Palmer; John M Coffin; Stephen H Hughes; Vineet N Kewalramani
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

4.  Alternative tRNA priming of human immunodeficiency virus type 1 reverse transcription explains sequence variation in the primer-binding site that has been attributed to APOBEC3G activity.

Authors:  Atze T Das; Monique Vink; Ben Berkhout
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Enhanced antiretroviral therapy in rhesus macaques improves RT-SHIV viral decay kinetics.

Authors:  Thomas W North; Andradi Villalobos; Selwyn J Hurwitz; Jesse D Deere; Joanne Higgins; Payel Chatterjee; Sijia Tao; Robert C Kauffman; Paul A Luciw; James J Kohler; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

6.  Frequent dual initiation in human immunodeficiency virus-based vectors containing two primer-binding sites: a quantitative in vivo assay for function of initiation complexes.

Authors:  Yegor A Voronin; Vinay K Pathak
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 7.  Nonhuman primate models of NeuroAIDS.

Authors:  Rachel Williams; Sirosh Bokhari; Peter Silverstein; David Pinson; Anil Kumar; Shilpa Buch
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

8.  Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy.

Authors:  Zandrea Ambrose; Sarah Palmer; Valerie F Boltz; Mary Kearney; Kay Larsen; Patricia Polacino; Leon Flanary; Kelli Oswald; Michael Piatak; Jeremy Smedley; Wei Shao; Norbert Bischofberger; Frank Maldarelli; Jason T Kimata; John W Mellors; Shiu-Lok Hu; John M Coffin; Jeffrey D Lifson; Vineet N KewalRamani
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

9.  HIV-1 Fitness and Replication Capacity: What Are They and Can They Help in Patient Management?

Authors:  Frank Maldarelli
Journal:  Curr Infect Dis Rep       Date:  2003-02       Impact factor: 3.725

10.  RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models.

Authors:  Yonghou Jiang; Baoping Tian; Mohammed Saifuddin; Michael B Agy; Peter Emau; J Scott Cairns; Che-Chung Tsai
Journal:  AIDS Res Ther       Date:  2009-11-05       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.